Intrapleural Chemo- and Hyperthermotherapies for Malignant Pleural Effusion: A Randomized Prospective Study

REFERENCES

• Pace E, Siena L, Ferraro M, Profita M, Mondello P, Chiappara G, Montalbano AM, Giarratano A, Bonsignore G, Gjomarkaj M. Role of prostaglandin E2 in the invasiveness, growth and protection of cancer cells in malignant pleuritis. Eur J Cancer 2006;42:2382–2389.
   PubMed Web of Science ®Google Scholar
• Figlin R, Mendoza E, Piantadosi S, Rusch V. Intrapleural chemotherapy without pleurodesis for malignant pleural effusions. LCSG Trial 861. Chest 1994;106:363S–366S.
   PubMed Web of Science ®Google Scholar
• American Thoracic Society. Management of malignant pleural effusions. Am J Respir Crit Care Med 2000;162:1987–2001.
   PubMed Web of Science ®Google Scholar
• Sahn SA. Malignancy metastatic to the pleura. Clin Chest Med 1998;19:351–361.
   PubMed Web of Science ®Google Scholar
• Sahn SA. Pleural diseases related to metastatic malignancies. Eur Respir J 1997;10:1907–1913.
   PubMed Web of Science ®Google Scholar
• Livingston RB, McCracken JD, Trauth CJ, Chen T. Isolated pleural effusion in small cell lung carcinoma: favorable prognosis. A review of the Southwest Oncology Group experience. Chest 1982;81:208–211.
   PubMed Web of Science ®Google Scholar
• Tan C, Sedrakyan A, Browne J, Swift S, Treasure T. The evidence on the effectiveness of management for malignant pleural effusion: a systematic review. Eur J Cardiothorac Surg 2006;29:829–838.
   PubMed Web of Science ®Google Scholar
• Neragi-Miandoab S. Malignant pleural effusion, current and evolving approaches for its diagnosis and management. Lung Cancer 2006;54:1–9.
   PubMed Web of Science ®Google Scholar
• Musani AI. Treatment options for malignant pleural effusion. Curr Opin Pulm Med 2009;15:380–387.
   PubMed Web of Science ®Google Scholar
• Ishida A, Miyazawa T, Miyazu Y, Iwamoto Y, Zaima M, Kanoh K, Sumiyoshi H, Doi M. Intrapleural cisplatin and OK432 therapy for malignant pleural effusion caused by non-small cell lung cancer. Respirology 2006;11:90–97.
   PubMed Web of Science ®Google Scholar
• Kataoka M, Morishita R, Hiramatsu J, Ueoka H, Nakata Y, Ohnoshi T, Kimura I, Harada M. OK-432 induces production of neutrophil chemotactic factors in malignant pleural effusion. Intern Med 1995;34:352–356.
   PubMed Web of Science ®Google Scholar
• Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981;47:207–214.
   PubMed Web of Science ®Google Scholar
• Stahel RA, Speak JA, Bernal SD. Murine monoclonal antibody LAM2 defines cell membrane determinant with preferential expression on human lung small-cell carcinoma and squamous-cell carcinomas. Int J Cancer 1985;35:11–17.
   PubMed Web of Science ®Google Scholar
• Putnam JB Jr, Light RW, Rodriguez RM, Ponn R, Olak J, Pollak JS, Lee RB, Payne DK, Graeber G, Kovitz KL. A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions. Cancer 1999;86:1992–1999.
   PubMed Web of Science ®Google Scholar
• Du Z, Zhou Y, Yang P. Sulfur dioxide derivatives increase a hyperpolarization-activated inward current in dorsal root ganglion neurons. Toxicology 2007;239:180–185.
   PubMed Web of Science ®Google Scholar
• Lombardi G, Zustovich F, Nicoletto MO, Donach M, Artioli G, Pastorelli D. Diagnosis and treatment of malignant pleural effusion: a systematic literature review and new approaches. Am J Clin Oncol 2010;33:420–423.
   PubMed Web of Science ®Google Scholar
• Ichinose Y, Yano T, Asoh H, Yokoyama H, Fukuyama Y, Miyagi J, Kuninaka S, Terazaki Y. Intraoperative intrapleural hypotonic cisplatin treatment for carcinomatous pleuritis. J Surg Oncol 1997;66:196–200.
   PubMed Web of Science ®Google Scholar
• Luh KT, Yang PC, Kuo SH, Chang DB, Yu CJ, Lee LN. Comparison of OK-432 and mitomycin C pleurodesis for malignant pleural effusion caused by lung cancer. A randomized trial. Cancer 1992;69:674–679.
   PubMed Web of Science ®Google Scholar
• Kimura M, Tojo T, Naito H, Nagata Y, Kawai N, Taniguchi S. Effects of a simple intraoperative intrathoracic hyperthermotherapy for lung cancer with malignant pleural effusion or dissemination. Interact Cardiovasc Thorac Surg 2010;10:568–571.
   PubMedGoogle Scholar
• Tattersall MH, Boyer MJ. Management of malignant pleural effusions. Thorax 1990;45:81–82.
   PubMed Web of Science ®Google Scholar
• Spiegler PA, Hurewitz AN, Groth ML. Rapid pleurodesis for malignant pleural effusions. Chest 2003;123:1895–1898.
   PubMed Web of Science ®Google Scholar
• Cascinu S, Isidori PP, Fedeli A, Fedeli SL, Raspugli M, Rossi A, Ugolini M, Catalano G. Experience with intrapleural natural beta interferon in the treatment of malignant pleural effusions. Tumori 1991;77:237–238.
   PubMed Web of Science ®Google Scholar
• Rosso R, Rimoldi R, Salvati F, De Palma M, Cinquegrana A, Nicolo G, Ardizzoni A, Fusco U, Capaccio A, Centofanti R, Neri M, Cruciani A, Maisto. Intrapleural natural beta interferon in the treatment of malignant pleural effusions. Oncology 1988;45:253–256.
   PubMed Web of Science ®Google Scholar
• Gebbia N, Mannino R, Di Dino A, Maxhouni L, Bellone N, Cinque L, Liuzza A, La Motta P, Cannata G, Gulotta G, Gebbia V. Intracavitary treatment of malignant pleural and peritoneal effusions in cancer patients. Anticancer Res 1994;14:739–745.
   PubMed Web of Science ®Google Scholar
• Goldman CA, Skinnider LF, Maksymiuk AW. Interferon instillation for malignant pleural effusions. Ann Oncol 1993;4:141–145.
   PubMed Web of Science ®Google Scholar
• Wilkins HE III, Connolly MM, Grays P, Marquez G, Nelson D. Recombinant interferon alpha-2b in the management of malignant pleural effusions. Chest 1997;111:1597–1599.
   PubMed Web of Science ®Google Scholar
• Antoniou KM, Ferdoutsis E, Bouros D. Interferons and their application in the diseases of the lung. Chest 2003;123:209–216.
   PubMed Web of Science ®Google Scholar
• Kawano M, Miura H, Anan H, Shimizu M. Treatment of secondary spontaneous pneumothorax complicating silicosis and progressive massive fibrosis. Kurume Med J 2002;49:35–40.
   PubMedGoogle Scholar
• Uchida A, Micksche M. Lysis of fresh human tumor cells by autologous peripheral blood lymphocytes and pleural effusion lymphocytes activated by OK432. J Natl Cancer Inst 1983;71:673–680.
   PubMed Web of Science ®Google Scholar
• Katano M, Morisaki T. The past, the present and future of the OK-432 therapy for patients with malignant effusions. Anticancer Res 1998;18:3917–3925.
   PubMed Web of Science ®Google Scholar
• Wei Y, Zhao X, Kariya Y, Fukata H, Teshigawara K, Uchida A. Induction of autologous tumor killing by heat treatment of fresh human tumor cells: involvement of gamma delta T cells and heat shock protein 70. Cancer Res 1996;56:1104–1110.
   PubMed Web of Science ®Google Scholar
• Rusch VW, Figlin R, Godwin D, Piantadosi S. Intrapleural cisplatin and cytarabine in the management of malignant pleural effusions: a Lung Cancer Study Group trial. J Clin Oncol 1991;9:313–319.
   PubMed Web of Science ®Google Scholar
• Tohda Y, Iwanaga T, Takada M, Yana T, Kawahara M, Negoro S, Okishio K, Kudoh S, Fukuoka M, Furuse K. Intrapleural administration of cisplatin and etoposide to treat malignant pleural effusions in patients with non-small cell lung cancer. Chemotherapy 1999;45:197–204.
   PubMed Web of Science ®Google Scholar
• Su WC, Lai WW, Chen HH, Hsiue TR, Chen CW, Huang WT, Chen TY, Tsao CJ, Wang NS. Combined intrapleural and intravenous chemotherapy, and pulmonary irradiation, for treatment of patients with lung cancer presenting with malignant pleural effusion. A pilot study. Oncology 2003;64:18–24.
   PubMed Web of Science ®Google Scholar
• Monjanel-Mouterde S, Frenay C, Catalin J, Boutin C, Durand A, Astoul P. Pharmacokinetics of intrapleural cisplatin for the treatment of malignant pleural effusions. Oncol Rep 2000;7:171–175.
   PubMed Web of Science ®Google Scholar
• Storm FK. Clinical hyperthermia and chemotherapy. Radiol Clin North Am 1989;27:621–627.
   PubMed Web of Science ®Google Scholar
• Walker-Renard PB, Vaughan LM, Sahn SA. Chemical pleurodesis for malignant pleural effusions. Ann Intern Med 1994;120:56–64.
   PubMed Web of Science ®Google Scholar
• Guirgis MF, Lueder GT. Choroidal neovascular membrane associated with optic nerve coloboma in a patient with CHARGE association. Am J Ophthalmol 2003;135:919–920.
   PubMed Web of Science ®Google Scholar